When you can't live without bananas

Get email updates of new posts:        (Delivered by FeedBurner)

Sunday, December 22, 2024

On Erin Reed and the Washington Post Editorial Board

Benjamin Ryan on X

Activist-blogger Erin Reed has published a guest article:
"Washington Post Editorial Board Misleadingly Attacks Care Of Trans Youth"

In, fact, many of the claims in this essay challenging WaPo are themselves misleading.

I will go through them in this 🧵⬇️ 

"It selectively cites three European reviews critical of gender-affirming care, while ignoring the consensus of leading medical organizations—including the American Academy of Pediatrics, the American Psychological Association, the American Medical Association, the Endocrine Society, and the World Professional Association for Transgender Health—all of which support such care."
▶️While WaPo hyperlinks to three European reviews, there have, in fact, been a half-dozen systematic literature reviews of pediatric gender-transition treatment. All of them have found the evidence backing such interventions weak and inconclusive.
▶️This has lead the health authorities in the UK and four Scandinavian nations to reclassify such treatment as experimental, and to sharply restrict access, in some cases to research settings only.
▶️The Cass Review found that WPATH and the US medical societies that endorse such interventions have engaged in "circularity," which is a more polite term for "citation laundering." WPATH made claims that were not supported by strong evidence in its 2013 Standards of Care 7. Then other US medical societies referred to those claims. And then it its SoC 8 in 2022, WPATH referred to those other societies, not mentioning that the claim they were referring to originated with WPATH. The near unanimity in these organizations is in part a product of the same people cross-pollinating their ideas from one organization to the next.  

*Hilary Cass was chosen not in spite of her lack of experience in pediatric gender medicine, but because of it. Ideally, people assessing the strength of evidence in a field will not have financial or intellectual conflicts of interest, as did every single author of WPATH's SoC8.
*A couple of dozen members of the BMA moved to denounce and scrutinize the Cass Review this summer. But after an internal outcry and a letter of protest signed by over 1,000 members, the BMA backpedaled and now has a neutral posture as it conducts its review of the Cass Review.
*Despite the fact that the Yale Law School put up the white paper criticizing Cass on its website, claiming it is the product of experts at Yale is a stretch. There is a Yale Law author, and otherwise Meredith McNamara is the lead author. Speaking of people who have no experience with pediatric gender medicine: she is such a person. Under pressure in a deposition in a Alabama civil case, she admitted that in her entire career as a pediatrician, she has only ever referred two patients to a pediatric gender clinic and has never prescribed pediatric gender-transition treatment. And yet she presents herself in myriad forums as a leading expert on this medical care.

Critics of the GRADE system who feel it holds pediatric gender-transition treatment to too high a standard, one that demands randomized controlled trials, can look, if they like, to the University of York systematic literature reviews that fed into the Cass Review. They used the Newcastle-Ottowa Scale, which allowed them to assess the observational research that makes up all the literature in the field of pediatric gender medicine.

Even with this more flexible standard, the reviews found of puberty blockers: "There is a lack of high-quality research assessing puberty suppression in adolescents experiencing gender dysphoria/incongruence. No conclusions can be drawn about the impact on gender dysphoria, mental and psychosocial health or cognitive development. Bone health and height may be compromised during treatment."

And of cross-sex hormones they found: "There is a lack of high-quality research assessing the use of hormones in adolescents experiencing gender dysphoria/incongruence. Moderate-quality evidence suggests mental health may be improved during treatment, but robust study is still required. For other outcomes, no conclusions can be drawn."

This RCT gave natal females testosterone immediately or on a three-month delay. During the early days of taking this hormone, it can cause an immediate feeling of euphoria. But it typically takes longer than this for the physical changes to set it. So a three-month delay is likely to be biased by the first factor and not include the impacts of the latter, the impact of which is what the trial should be measuring. So no, this is hardly a definitive, high quality RCT that is free from bias and whose findings likely reflect real world impact. jamanetwork.com/journals/jaman…

*The entire pediatric gender medicine global field got started because of a tiny study of just 70 people, and 55 during it's last follow-up, out of the Netherlands (published in 2011 and 2014).
*The researchers at the NHS pediatric gender clinic, GIDS, attempted to replicate those findings with what ultimately included 44 participants. While the Dutch study had various positive findings (which have been criticized by many researchers, mind you), this study found null findings. The youth did not improve psychologically. But the purpose of the study was indeed to demonstrate that they would. Thus, the study was a failure. And so the researchers hid the findings for years until Oxford sociologist Michael Biggs smoked it out.
* The notion that puberty blockers provide a time to think should have been put to rest long ago. Numerous analyses have shown that almost everyone who starts blockers for gender dysphoria goes on to take cross-sex hormones. It is extremely unlikely that this is because the assessments for kids seeking blockers were nearly perfect. That just does not happen in psychology.
*The reference to the 72% suicidal ideation is misleading in various ways. For one, the study was mostly concerned with sports laws, not gender-transition treatment. So it is not right to hold it up as solid proof that such bans lead to suicidal attempts. Also, the study was about suicidal attempts ,not ideation. Actually, oddly, it found that there was evidence these laws led to attempts, but NOT to ideation. And it found that they led to such attempts 2 years later, but not 1 or 3 years later. It's a messy study to say the least.

The citation laundering diagram:

James Cantor’s critique and fact check of the AAP’s 2018 policy statement of the gender-affirming care method, which the organization has never responded to.

ohchr.org/sites/default/…
 
As for WPATH’s treatment guidelines, subpoenaed documents revealed that WPATH leadership suppressed systematic literature reviews it commissioned when they were unhappy with the findings; were aware of the weakness of the evidence behind their recommendations; papered over that weakness; added language like “medically necessary” that was not backed by science but was meant to help secure insurance coverage and win lawsuits; and coordinated with the ACLU on that final strategy.
 
There's other stuff I could've gone into in this Erin In the Morning piece. But you get the point.

The person who wrote this piece for Erin has once expressed that they saw it as a badge of honor that I fact checked them.

It is not.

blog comments powered by Disqus
Related Posts Plugin for WordPress, Blogger...

Latest posts (which you might not see on this page)

powered by Blogger | WordPress by Newwpthemes